Log inSign up
Columbia Division of Infectious Diseases
125 posts
Columbia Division of Infectious Diseases profile banner
@cuimc_id

Columbia Division of Infectious Diseases

@cuimc_id
Advancing patient care and science. Official twitter account of @ColumbiaMed’s Division of Infectious Diseases and Fellowship Training Program
New York, NY, United States
infectiousdiseases.cuimc.columbia.edu
Joined February 2022
104
Following
731
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @cuimc_id
    Columbia Division of Infectious Diseases
    @cuimc_id
    Nov 14, 2024
    Tomorrow! @cuimc_id faculty lead this fantastic review course! eventleaf.com/e/ID2024 #Hospitalist #InfectiousDiseases #MedEd #HAI @ColumbiaMed
  • @cuimc_id
    Columbia Division of Infectious Diseases
    @cuimc_id
    Oct 22, 2024
    Don't miss @ColumbiaMed Grand Rounds with Dr. Olender tomorrow!
  • @cuimc_id
    Columbia Division of Infectious Diseases
    @cuimc_id
    Oct 21, 2024
    Absolutely thrilled that Dr. Jay Vyas has joined the Columbia ID and VP&S family! @ColumbiaMed @ColumbiaPS @jmvyasmdphd cuimc.columbia.edu/news/jay-vyas-…
    1
  • @cuimc_id
    Columbia Division of Infectious Diseases
    @cuimc_id
    Oct 21, 2024
    Fabulous presentations by our ID Fellows at #IDWeek2024!!!!
  • @cuimc_id
    Columbia Division of Infectious Diseases
    @cuimc_id
    Oct 18, 2024
    Proud to have been a part of this seminal clinical trial here @ColumbiaMed @m_pereiramd
    @NEJM
    NEJM
    @NEJM
    Oct 16, 2024
    In a study involving kidney-transplantation candidates with HIV, results of transplantation from donors with HIV were noninferior to those of transplantation from donors without HIV. Full study results: nej.md/4fpjvML
    The cumulative incidence of a safety event (primary outcome), which was defined as a composite of death from any cause, graft loss, serious adverse event, human immunodeficiency virus (HIV) breakthrough infection, persistent failure of HIV treatment, or opportunistic infection, among kidney-transplant recipients with HIV.